ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
TC BioPharm Holdings PLC

TC BioPharm Holdings PLC (TCBP)

1.10
-0.03
( -2.65% )
Updated: 14:55:26

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.10
Bid
1.09
Ask
1.10
Volume
172,479
1.09 Day's Range 1.15
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.13
Open
1.13
Last Trade
1
@
1.1
Last Trade Time
14:56:08
Financial Volume
$ 191,560
VWAP
1.1106
Average Volume (3m)
-
Shares Outstanding
950,000
Dividend Yield
-
PE Ratio
-0.75
Earnings Per Share (EPS)
-1.46
Revenue
3.85M
Net Profit
-1.39M

About TC BioPharm Holdings PLC

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Headquarters
Scotland, Gbr
Founded
1970
TC BioPharm Holdings PLC is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker TCBP. The last closing price for TC BioPharm was $1.13. Over the last year, TC BioPharm shares have traded in a share price range of $ 0.00 to $ 0.00.

TC BioPharm currently has 950,000 shares outstanding. The market capitalization of TC BioPharm is $1.05 million. TC BioPharm has a price to earnings ratio (PE ratio) of -0.75.

TCBP Latest News

TCBP Announces Launch of Compassionate Use Program for TCB008

TCBP Announces Launch of Compassionate Use Program for TCB008 PR Newswire EDINBURGH, Scotland, May 15, 2024 The Company's lead therapeutic will be available through a newly opened compassionate...

TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds

TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds PR Newswire EDINBURGH, Scotland, May 6, 2024 EDINBURGH, Scotland, May 6, 2024 /PRNewswire/ -- TC BioPharm (Holdings) plc...

TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies

TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies PR Newswire EDINBURGH, Scotland, May 6, 2024 Acquisition target has...

TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies

TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies PR Newswire EDINBURGH, Scotland, April 4, 2024 EDINBURGH, Scotland, April 4, 2024 /PRNewswire/...

TCBP Increasing Treatment Capacity with Expanded Manufacturing Process

TCBP Increasing Treatment Capacity with Expanded Manufacturing Process PR Newswire EDINBURGH, Scotland, April 2, 2024 Developing streamlined approach to reduce cost per patient by 85%EDINBURGH...

TCBP Adjourns General Meeting Until a Later Date

TCBP Adjourns General Meeting Until a Later Date PR Newswire EDINBURGH, Scotland, March 19, 2024 EDINBURGH, Scotland, March 19, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or...

TCBP Announces Exercise of Series D Warrants For Cash

TCBP Announces Exercise of Series D Warrants For Cash PR Newswire EDINBURGH, Scotland, March 18, 2024 •  Company receives gross proceeds of $1.26 M from transaction EDINBURGH, Scotland, March 18...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GTBPGT Biopharma Inc
$ 7.77
(149.04%)
61.71M
MMVMultiMetaVerse Holdings Ltd
$ 1.2393
(109.77%)
125.2M
FFIEFaraday Future Intelligent Electric Inc
$ 1.5309
(48.63%)
624.37M
TANHTantech Holdings Ltd
$ 0.959
(45.97%)
61.95M
PEGYPineapple Energy Inc
$ 0.15
(42.31%)
249.5M
MTCMMTec Inc
$ 1.114
(-84.11%)
46.53M
AKTSAkoustis Technologies Inc
$ 0.1599
(-55.11%)
18.31M
VIRIVirios Therapeutics Inc
$ 0.1897
(-46.02%)
5.03M
FLJFLJ Group Limited
$ 0.8756
(-43.51%)
4.24M
JAGXJaguar Health Inc
$ 0.1641
(-36.52%)
57.7M
CRKNCrown Electrokinetics Corporation
$ 0.202
(18.13%)
680.19M
FFIEFaraday Future Intelligent Electric Inc
$ 1.5309
(48.63%)
624.37M
GWAVGreenwave Technology Solutions Inc
$ 0.1482
(-3.83%)
321.12M
BRSHBruush Oral Care Inc
$ 0.152
(29.69%)
252.88M
PEGYPineapple Energy Inc
$ 0.15
(42.31%)
249.5M

TCBP Discussion

View Posts
surf1944 surf1944 2 weeks ago
https://stockcharts.com/h-sc/ui?s=tcbp&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/tcbp/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/tcbp/opinion

https://finance.yahoo.com/quote/tcbp/

Bottom bounce coming!
👍️0
Awl416 Awl416 2 weeks ago
TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies
👍️0
glenn1919 glenn1919 2 months ago
TCBP...............................https://stockcharts.com/h-sc/ui?s=TCBP&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 2 months ago
Will it grow legs after 9:30
👍️0
Awl416 Awl416 2 months ago
TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies
👍️0
Awl416 Awl416 2 months ago
Smells in here given that volume of 130m
👍️0
Invest-in-America Invest-in-America 2 months ago
TCBP: But, nobody interested --- whatever works.
👍️0
surf1944 surf1944 3 months ago
https://stockcharts.com/h-sc/ui?s=tcbp&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/tcbp/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/tcbp/opinion

https://finance.yahoo.com/quote/tcbp/

Chart bounce candidate!
👍️0
Monksdream Monksdream 3 months ago
TCBP new 52 week low
👍️0
EyalCap EyalCap 3 months ago
$TCBP The acceptance of TC BioPharm’s amendment by the MHRA for the ACHIEVE UK trial can be seen as a bullish signal for several reasons:

1. Enhanced Trial Flexibility: The ability to increase the dose level for TCB008 and shift to an outpatient procedure may improve the trial’s efficiency and patient experience. This flexibility could potentially lead to better trial outcomes and patient adherence.
2. Operational Efficiency: Reducing the need for overnight hospital stays for patients after dosing not only improves the quality of life for participants but also eases the burden on clinical sites. This operational efficiency can accelerate the trial’s progress.
3. Positive Regulatory Feedback: Gaining regulatory acceptance for amendments suggests a positive interaction between TC BioPharm and regulatory bodies, indicating that the company is responsive and adaptable to both regulatory requirements and clinical insights.
4. Potential Impact on FDA Trial: The amendments align with the dosing levels of the Investigational New Drug (IND) application for the second cohort, which might streamline the process for the FDA trial. This proactive approach to aligning international trial standards may facilitate smoother regulatory negotiations and trial implementations in multiple jurisdictions.
5. Innovative Treatment Potential: The focus on TCB008 and its application in treating Acute Myeloid Leukemia (AML) underscores TC BioPharm’s commitment to developing innovative cancer treatments. Success in these trials could position the company as a leader in gamma-delta T cell therapies, potentially opening up significant market opportunities.
👍️0
elks elks 3 months ago
Chart bottom looks like.
👍️0
glenn1919 glenn1919 3 months ago
TCBP..................................https://stockcharts.com/h-sc/ui?s=TCBP&p=W&b=5&g=0&id=p86431144783
👍️0
elks elks 3 months ago
I want double digits
👍️0
londonohoyos londonohoyos 3 months ago
How high might it go
👍️0
elks elks 3 months ago
In.
👍️0
TheFinalCD TheFinalCD 3 months ago
tcbp $2 break
👍️0
tw0122 tw0122 3 months ago
Looking better $1.80s premarket and warrants should be out of way next push.


"Series E Warrants") to purchase up to 1,750,000 of its ADSs at a public offering price of $2.00 per ADS (or pre-funded warrant in lieu thereof) and associated Series
👍️0
Monksdream Monksdream 3 months ago
Wash trade du jour in the making
👍️0
TheFinalCD TheFinalCD 3 months ago
CORRECTION: I found out he was trying to get Dave Portnoys attention, thats why he kept tagging him in his posts

not that Dave from BAR STOOLS has anything to do with or even a shareholder of TCBP
👍️0
TheFinalCD TheFinalCD 3 months ago
https://stocktwits.com/ProfessorDman1/message/560859418
👍️0
TheFinalCD TheFinalCD 3 months ago
this guy is claiming the Dave Portnoy gave this pick @ .90?

Im still trying to figure it out

Yesterday .90s https://t.co/u5JxgsgSwo pic.twitter.com/VzxPdy2Cdc— professor D🔥man (@professorDman1) February 8, 2024

$TCBP 1.49 Dave @stoolpresidente @Stocktwits we gonna see double digits run— professor D🔥man (@professorDman1) February 9, 2024

Dave @stoolpresidente gave you this yesterday .90s $TCBP we are gonna see 5-7 run then 10-20+ run maybe $50+ like what $HOLO did > with right volume n news which is due ! This is billion dollar market industry… pic.twitter.com/xCgbVxKVu8— professor D🔥man (@professorDman1) February 8, 2024
👍️0
londonohoyos londonohoyos 3 months ago
When is it going to stop going down
👍️0
Monksdream Monksdream 3 months ago
TCBP new 52 week low
👍️0
Monksdream Monksdream 3 months ago
TCBP new 52 week low
👍️0
Monksdream Monksdream 4 months ago
TCBP new 52 week low
👍️0
surf1944 surf1944 4 months ago
https://stockcharts.com/h-sc/ui?s=tcbp&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/tcbp/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/tcbp/opinion

https://finance.yahoo.com/quote/tcbp/

Looking for a bottom in TCBP!
👍️0
Monksdream Monksdream 4 months ago
TCBP new 52 week low
👍️0
glenn1919 glenn1919 4 months ago
TCBP............................https://stockcharts.com/h-sc/ui?s=TCBP&p=W&b=5&g=0&id=p86431144783
👍️0
microcapbiotech microcapbiotech 5 months ago
Sold later in afternoon at $3.16. Will wait unti after the coming RS.
👍️0
microcapbiotech microcapbiotech 5 months ago
Started a position today (1-2-24) in TCBP at $3.08. With a market cap of just 2.4 million and only 752 thousand shares outstanding, figure it is worth a shot.
👍️0
TheFinalCD TheFinalCD 5 months ago
1/18/2023, 1:55:43 PMPre-funded warrants likely all exercised and sold already. Current float closer to 2m.
https://dilutiontracker.com/app/search/TCBP?a=dbb88c
👍️0
Disquisition Disquisition 5 months ago
OFFERING!!!! Baw haw haw haw
👍️0
Disquisition Disquisition 5 months ago
SUSTAINED DUMPING
👍️0
starkd748 starkd748 6 months ago
They dumped very hard on news
👍️0
starkd748 starkd748 6 months ago
Dumping shares on news wow... Watching for mow
👍️0
Sly1969 Sly1969 6 months ago
Yes they are. No doubts here. IND application approval decision was due yesterday. News any day. Most likely Monday morning.
👍️0
TKgreen TKgreen 6 months ago
Their gonna miss a HUGE RUN!!
👍️0
Awl416 Awl416 6 months ago
Pm volume
👍️0
Sly1969 Sly1969 6 months ago
I see this board still sleeping on TCBP with IND application approval pending for AML patients who are refractory/relapse .
👍️0
TKgreen TKgreen 6 months ago
https://ir.tcbiopharm.com/news/press-releases/detail/67/tc-biopharm-announces-successful-completion-of-safety
👍️ 1
Sly1969 Sly1969 6 months ago
Article pertinent to TCBP regarding AML treatment that mentions TCBP at the end.https://www.barchart.com/story/news/21369384/why-the-relapsedrefractory-acute-myeloid-leukemia-market-is-expected-to-witness-revolutionary-developments
👍️0
Sly1969 Sly1969 6 months ago
Ceo interview on podcast
👍️0
resx18 resx18 7 months ago
Big Boys in control #WeHaveThePower $TCBP
👍️ 1 🖕 1
resx18 resx18 7 months ago
#WeHaveThePower $TCBP
🍻 1 🚀 1
resx18 resx18 7 months ago
SONIC BOOM >> $TCBP
👍️ 1
resx18 resx18 7 months ago
Our team is looking forward to the continued clinical and platform expansions in 2024, and anticipate multiple milestone achievements in the next 12 months for investors
👍️ 1
resx18 resx18 7 months ago
"We feel that Excellos is an ideal partner for TCBP, sharing our entrepreneurial spirit and belief in a collaborative effort to advance cell therapies globally," commented CEO Bryan Kobel. "We believe this step materially strengthens our ability to deliver on multiple clinical fronts and creates economic efficiencies within our production planning, while also maintaining our manufacturing autonomy for the final product. Our team is looking forward to the continued clinical and platform expansions in 2024, and anticipate multiple milestone achievements in the next 12 months for investors."
👍️0
resx18 resx18 7 months ago
Nice Day here $TCBP
👍️0
resx18 resx18 7 months ago
Good Morning $TCBP
👍️0
resx18 resx18 7 months ago
Strong volume .. tons of loading. $TCBP
👍️ 1

Your Recent History

Delayed Upgrade Clock